The menopause transition: signs, symptoms, and management options

N Santoro, C Roeca, BA Peters… - The Journal of Clinical …, 2021‏ - academic.oup.com
Context Menopause, the permanent cessation of menses, reflects oocyte depletion and loss
of gonadal steroids. It is preceded by a transition state, the perimenopause, which is …

Hormone-replacement therapy: current thinking

RA Lobo - Nature Reviews Endocrinology, 2017‏ - nature.com
For several decades, the role of hormone-replacement therapy (HRT) has been debated.
Early observational data on HRT showed many benefits, including a reduction in coronary …

Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women's health initiative randomized clinical …

RT Chlebowski, GL Anderson, AK Aragaki… - Jama, 2020‏ - jamanetwork.com
Importance The influence of menopausal hormone therapy on breast cancer remains
unsettled with discordant findings from observational studies and randomized clinical trials …

2016 IMS Recommendations on women's midlife health and menopause hormone therapy

RJ Baber, N Panay, A Fenton - Climacteric, 2016‏ - Taylor & Francis
Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …

[HTML][HTML] Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials

JAE Manson, AK Aragaki, JE Rossouw, GL Anderson… - Jama, 2017‏ - jamanetwork.com
Importance Health outcomes from the Women's Health Initiative Estrogen Plus Progestin
and Estrogen-Alone Trials have been reported, but previous publications have generally not …

Treatment of symptoms of the menopause: an endocrine society clinical practice guideline

CA Stuenkel, SR Davis, A Gompel… - The Journal of …, 2015‏ - academic.oup.com
Objective: The objective of this document is to generate a practice guideline for the
management and treatment of symptoms of the menopause. Participants: The Treatment of …

Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women's health initiative randomized clinical trials

ML Neuhouser, AK Aragaki, RL Prentice… - JAMA …, 2015‏ - jamanetwork.com
Importance More than two-thirds of US women are overweight or obese, placing them at
increased risk for postmenopausal breast cancer. Objective To investigate in this secondary …

Menopausal hormone therapy and health outcomes during the intervention and extended poststop** phases of the Women's Health Initiative randomized trials

JAE Manson, RT Chlebowski, ML Stefanick… - Jama, 2013‏ - jamanetwork.com
Importance Menopausal hormone therapy continues in clinical use but questions remain
regarding its risks and benefits for chronic disease prevention. Objective To report a …

Estrogen receptors and the aging brain

S Maioli, K Leander, P Nilsson… - Essays in Biochemistry, 2021‏ - portlandpress.com
The female sex hormone estrogen has been ascribed potent neuroprotective properties. It
signals by binding and activating estrogen receptors that, depending on receptor subtype …

Risks, benefits, and treatment modalities of menopausal hormone therapy: current concepts

J Mehta, JM Kling, JAE Manson - Frontiers in endocrinology, 2021‏ - frontiersin.org
Menopausal hormone therapy (HT) prescribing practices have evolved over the last few
decades guided by the changing understanding of the treatment's risks and benefits. Since …